IL-17 Blockade to Decrease irAEs (REPLAY)

Clinical trial NCT07237594 · RECRUITING

Trial details

NCT number: NCT07237594
Sponsor: Duke University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2026-03-12
Primary completion: 2027-06-30
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.